drugset / Trial / NCT00950651

A Comparison of the Analgesic Efficacy and Safety of Once Daily Tramadol HCl / Contramid® Tablets to Twice Daily Tramadol HCl (SR) for the Treatment of Osteoarthritis of the Knee

NCT00950651

Phase 3 Completed 431 enrolled Labopharm Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

A randomised, multi-centre, double-blind, double dummy, two arm parallel design study to compare the efficacy, safety, and clinical benefit of the test and reference product after treatment for 84 days in patients with osteoarthritis of the knee.

Timeline

Start
2002-03
Primary completion
2002-11
Completion
2002-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tramadol Other / unclassified 100 mg Oral
Comparator Tramadol Other / unclassified 200 mg Oral
Comparator Tramadol Other / unclassified 300 mg Oral
Comparator Tramadol Other / unclassified 400 mg Oral

Indications